NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/06/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the words "My NavCare", with the word "My" in orange, and the words "NavCare" in green over the words "PATIENT SUPPORT" in grey; a stylized star in orange is positioned at the top of the letter "N" in "NavCare".
Titulares
Representantes
Max Vern Amster, Rothstein & Ebenstein LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Classe 36
Financial administration of patient reimbursement and patient financial assistance programs, namely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable services, namely, providing financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; Healthcare insurance services, namely, insurance eligibility review and verification, consultation and information in connection with patient reimbursement and patient financial assistance programs; Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical treatments; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Classe 44
Medical assistance, namely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care services, namely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Classe 45
Providing personal support services for patients and families of patients in connection to disease management and navigation through medical treatments, namely, emotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders in connection to disease management and reimbursement of medical expenses, namely, companionship, help with medical forms, emotional counseling and emotional support; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/06/2025
REGISTERED-PRINCIPAL REGISTER
03/06/2025
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/05/2025
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/05/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
25/04/2025
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/04/2025
ASSIGNED TO LIE
25/04/2025
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2025
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/02/2025
NON-FINAL ACTION E-MAILED
13/02/2025
SU - NON-FINAL ACTION - WRITTEN
13/02/2025
STATEMENT OF USE PROCESSING COMPLETE
23/01/2025
CASE ASSIGNED TO INTENT TO USE PARALEGAL
23/01/2025
USE AMENDMENT FILED
07/11/2024
TEAS STATEMENT OF USE RECEIVED
07/11/2024
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/05/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/03/2024
PUBLISHED FOR OPPOSITION
19/03/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/02/2024
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
14/02/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
31/01/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/01/2024
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/01/2024
NON-FINAL ACTION E-MAILED
23/01/2024
NON-FINAL ACTION WRITTEN
23/01/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
18/01/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/01/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/01/2024
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/01/2024
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
15/01/2024
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/01/2024
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/01/2024
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/01/2024
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/01/2024
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/10/2023
NON-FINAL ACTION E-MAILED
17/10/2023
NON-FINAL ACTION WRITTEN
17/10/2023
ASSIGNED TO EXAMINER
11/10/2023
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/09/2023
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/09/2023
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/09/2023
NOTICE OF DESIGN SEARCH CODE E-MAILED
14/06/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/06/2023
NEW APPLICATION ENTERED
18/05/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.